AK

Akhilnath Kunnencheri

Active Director Director DIN 09771989
DIN 09771989 First appointment Oct 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Akhilnath Kunnencheri

Data last updated:

Akhilnath Kunnencheri is a Director at Balot Pharmaceuticals Private Limited (since 2022). The company operates in Chemicals.

DIN 09771989
Primary Designation Director
Industry Chemicals
First Appointment 20 Oct 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Oct 20222022Active

Directorship timeline

Open interactive timeline →
Balot Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Akhilnath Kunnencheri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akhilnath Kunnencheri

Akhilnath Kunnencheri currently holds 1 directorship: Balot Pharmaceuticals Private Limited (Director, since 20 Oct 2022).

Akhilnath Kunnencheri was first appointed on 20 Oct 2022 as Director at Balot Pharmaceuticals Private Limited.

The current boards of Akhilnath Kunnencheri's companies include Ajin Lal Mela Puliyangatt (Balot Pharmaceuticals Private Limited), Jithin Uttu Kulathil (Balot Pharmaceuticals Private Limited), Kattayattu Parambath Shobith (Balot Pharmaceuticals Private Limited), Midhun Mambatta (Balot Pharmaceuticals Private Limited), Sarath (Balot Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available